These occur in a significant proportion of patients, particularly during dose escalation
The recovery research is built around this window: the 2021 randomized controlled trial (PMID 34684429) measured improved recovery, reduced soreness, and blunted strength loss over a five-week protocol, with the curve building through the back half
References Davies M, et al
In clinical trials tirzepatide showed higher average weight loss (up to ~20%) than semaglutide (~15% over 68 weeks), but the right choice depends on your health history and your clinicians guidance
Weight Watchers Med+ helps make accessing a weight-loss medication convenient and easy, if you qualify, through a brand you know and trust
10.2217/pgs.12.11 Pharmacogenomics 57 FerrariM.GuastiL.MarescaA.MirabileM.ContiniS.GrandiA